IBBQ

Invesco Nasdaq Biotechnology ETF
NasdaqGMUSDETF / FUND DELAYED
Last price
34.01
▲ 0.11 (0.32%)
MARKET · —

Price

1D — H — L — Range — Vol —
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
33.78
Prev close
33.90
Day high
34.39
Day low
33.63
Volume
103.66K
Market cap
—
P/E (TTM)
25.11
52W range
25.00 – 36.84

Day trading desk

Current session · delayed
Gap from prior close
-0.35%
Prior close 33.90
VWAP
34.19
-0.52% from price
Relative volume
3.23×
Unusually busy
Session range
2.26%
33.63 – 34.39
Position in range
50%
Mid range
ATR (14D)
0.70
2.05% of price
Prior day high
34.94
PDH
Prior day low
33.66
PDL
Bid / ask spread
—
Quote not published
Session volume
105.70K
Avg 32.71K

VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
-3.22% -5.1%
1M
-3.38% -4.9%
3M
+0.12% -3.3%
6M
+15.59% +0.6%
YTD
+19.77% +5.8%
1Y
+34.83% +19.1%
3Y
+74.05% -7.8%
5Y
— —

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Top holdings

10 shown · by weight
SymbolNameWeight
GILD Gilead Sciences Inc 8.16%
AMGN Amgen Inc 7.85%
VRTX Vertex Pharmaceuticals Inc 7.69%
MRNA Moderna Inc 5.04%
REGN Regeneron Pharmaceuticals Inc 5.02%
RVMD Revolution Medicines Inc Ordinary Shares 2.88%
ILMN Illumina Inc 2.71%
BIIB Biogen Inc 2.19%
ALNY Alnylam Pharmaceuticals Inc 2.16%
ROIV Roivant Sciences Ltd Ordinary Shares 1.73%

Sector exposure

Fund weightings
Healthcare
100.00%

Fund profile

As reported
Fund familyInvesco
CategoryHealth
Legal typeExchange Traded Fund
Expense ratio0.19%
Turnover17.0%
Total net assets$25.67M

Unusual options activity

Account required
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
Free account required

Contracts trading at or above their open interest, ranked by notional and where the print landed.

Free account

5 more panels on IBBQ open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Fundamentals

TTM · reported
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—

Valuation & profitability ratios

Account required
Trailing P/E25.11
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Options analytics

Account required
Put / call volume
0.00
Call-heavy session
Put / call open interest
—
Positioning, not flow
Max pain
25.00
-26.5% from spot
ATM implied vol
6.3%
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
5
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
25.00
0 contracts
Heaviest put OI
—
—

Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.

Free account required

Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.

Analyst targets & ownership

Account required
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
34.71
-2.01% from price
SMA 20
34.71
-2.02% from price
SMA 50
34.70
-2.00% from price
SMA 100
32.84
+3.56% from price
SMA 200
31.02
+9.63% from price
EMA 12
34.60
-1.71% from price
EMA 26
34.75
-2.12% from price
EMA 50
34.38
-1.07% from price
RSI (14)
42.2
Neutral
MACD (12,26,9)
-0.15
Hist -0.14
ATR (14)
0.70
2.05% of price
Realised vol 30D
19.8%
Annualised
Bollinger upper
35.54
20, 2σ
Bollinger lower
33.88
20, 2σ
50 / 200 cross
Golden
34.70 vs 31.02
Trend bias
Above 200
+9.63%

Options chain

Account required
Expiry
Spot 34.01
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Risk profile

Daily returns · 1Y window
Beta vs SPY
0.72
Less volatile than market
Correlation to SPY
0.43
Loosely linked
Realised vol 30D
19.8%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-8.5%
Peak to trough
Max drawdown 5Y
-35.2%
Peak to trough
ATR 14
0.70
2.05% of price
Beta (reported)
—
5Y monthly, from filing

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.